Phosphoproteomics identifies a bimodal EPHA2 receptor switch that promotes embryonic stem cell differentiation

Nat Commun. 2020 Mar 13;11(1):1357. doi: 10.1038/s41467-020-15173-4.

Abstract

Embryonic Stem Cell (ESC) differentiation requires complex cell signalling network dynamics, although the key molecular events remain poorly understood. Here, we use phosphoproteomics to identify an FGF4-mediated phosphorylation switch centred upon the key Ephrin receptor EPHA2 in differentiating ESCs. We show that EPHA2 maintains pluripotency and restrains commitment by antagonising ERK1/2 signalling. Upon ESC differentiation, FGF4 utilises a bimodal strategy to disable EPHA2, which is accompanied by transcriptional induction of EFN ligands. Mechanistically, FGF4-ERK1/2-RSK signalling inhibits EPHA2 via Ser/Thr phosphorylation, whilst FGF4-ERK1/2 disrupts a core pluripotency transcriptional circuit required for Epha2 gene expression. This system also operates in mouse and human embryos, where EPHA receptors are enriched in pluripotent cells whilst surrounding lineage-specified trophectoderm expresses EFNA ligands. Our data provide insight into function and regulation of EPH-EFN signalling in ESCs, and suggest that segregated EPH-EFN expression coordinates cell fate with compartmentalisation during early embryonic development.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Differentiation / genetics
  • Cell Differentiation / physiology*
  • Embryo, Mammalian / metabolism*
  • Embryonic Development / genetics
  • Embryonic Development / physiology
  • Embryonic Stem Cells / metabolism*
  • Ephrin-A2
  • Fibroblast Growth Factor 4 / metabolism
  • Humans
  • Ligands
  • MAP Kinase Signaling System
  • Mice
  • Phosphorylation
  • Proteomics / methods*
  • Receptor, EphA2 / genetics
  • Receptor, EphA2 / metabolism*
  • Signal Transduction

Substances

  • EPHA2 protein, human
  • Ephrin-A2
  • FGF4 protein, human
  • Fibroblast Growth Factor 4
  • Ligands
  • Receptor, EphA2